Literature DB >> 10873917

Neuropsychological deficits in psychotic versus nonpsychotic major depression and no mental illness.

A F Schatzberg1, J A Posener, C DeBattista, B M Kalehzan, A J Rothschild, P K Shear.   

Abstract

OBJECTIVE: At least three studies have indicated that patients with psychotic major depression studied under non-drug-free conditions differ from patients with nonpsychotic major depression and healthy comparison subjects on several measures of neuropsychological performance. The current study explored specific impairments in cognitive function in subjects with psychotic major depression, subjects with nonpsychotic major depression, and healthy comparison subjects studied under drug-free conditions.
METHOD: A battery of neuropsychological tests was administered to 11 patients with psychotic major depression, 32 patients with nonpsychotic major depression, and 23 normal comparison subjects under drug-free conditions. The three groups did not differ statistically in age, sex, or level of education. To ensure that participants had minimal levels of severity and endogenicity, all patients were required to have a score of at least 20 on the 21-item Hamilton Depression Rating Scale and a score of at least 7 on the Core Endogenomorphic Scale, which uses eight items from the Hamilton depression scale.
RESULTS: Patients with psychotic major depression demonstrated significantly greater impairment than patients with nonpsychotic major depression and/or comparison subjects in attention and response inhibition (as measured by the Stroop color-word subscale score) as well as in verbal declarative memory (as measured by the Paragraph Recall Test).
CONCLUSIONS: These data indicate that patients with psychotic major depression demonstrate impairment in functions thought to be mediated by the frontal cortex and mediotemporal lobes.

Entities:  

Mesh:

Year:  2000        PMID: 10873917     DOI: 10.1176/appi.ajp.157.7.1095

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  45 in total

1.  Stress-level cortisol treatment impairs inhibitory control of behavior in monkeys.

Authors:  D M Lyons; J M Lopez; C Yang; A F Schatzberg
Journal:  J Neurosci       Date:  2000-10-15       Impact factor: 6.167

2.  The GABAergic deficit hypothesis of major depressive disorder.

Authors:  B Luscher; Q Shen; N Sahir
Journal:  Mol Psychiatry       Date:  2010-11-16       Impact factor: 15.992

Review 3.  Major depressive disorder is associated with broad impairments on neuropsychological measures of executive function: a meta-analysis and review.

Authors:  Hannah R Snyder
Journal:  Psychol Bull       Date:  2012-05-28       Impact factor: 17.737

Review 4.  Psychotic major depression: a benefit-risk assessment of treatment options.

Authors:  Audrey R Tyrka; Lawrence H Price; Marcelo F Mello; Andrea F Mello; Linda L Carpenter
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

5.  Delusional versus nondelusional body dysmorphic disorder: clinical features and course of illness.

Authors:  K A Phillips; W Menard; M E Pagano; C Fay; R L Stout
Journal:  J Psychiatr Res       Date:  2005-10-17       Impact factor: 4.791

Review 6.  Diagnosing schizophrenia circa 2005: how and why?

Authors:  Laurie M McCormick; Michael Flaum
Journal:  Curr Psychiatry Rep       Date:  2005-08       Impact factor: 5.285

7.  Neuropsychological profile in early-onset schizophrenia-spectrum disorders: measured with the MATRICS battery.

Authors:  Aina Holmén; Monica Juuhl-Langseth; Rune Thormodsen; Ingrid Melle; Bjørn Rishovd Rund
Journal:  Schizophr Bull       Date:  2009-02-17       Impact factor: 9.306

Review 8.  Specifying the neuropsychology of affective disorders: clinical, demographic and neurobiological factors.

Authors:  Thomas Beblo; Grant Sinnamon; Bernhard T Baune
Journal:  Neuropsychol Rev       Date:  2011-06-10       Impact factor: 7.444

9.  Hippocampal and amygdalar volumes in psychotic and nonpsychotic unipolar depression.

Authors:  Jennifer Keller; Lin Shen; Rowena G Gomez; Amy Garrett; H Brent Solvason; Allan Reiss; Alan F Schatzberg
Journal:  Am J Psychiatry       Date:  2008-05-01       Impact factor: 18.112

Review 10.  Glucocorticoid dysregulations and their clinical correlates. From receptors to therapeutics.

Authors:  Andrea H Marques; Marni N Silverman; Esther M Sternberg
Journal:  Ann N Y Acad Sci       Date:  2009-10       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.